Alpha Teknova, Inc. (NasdaqGM: TKNO)
Health Care · Life Sciences Tools & Services · US
$8.53
-3.51% today · +76.4% 1Y
Alpha Teknova, Inc. (NasdaqGM: TKNO) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $474.60M and employs 158 people.
Over the last twelve months the share price has gained 76.4%, trading between 1.91 and 9.48.
Tweenvest scores Alpha Teknova, Inc. across four factors: quality 63/100, value 63/100, growth 56/100. Its strongest factor is quality.
TKNO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $474.60M
- Revenue (TTM)
- $43.70M
- P/E
- —
- EPS
- -0.31
- Dividend yield
- —
- Beta (5Y)
- 0.86
- 52-week high
- $9.48
- 52-week low
- $1.91
- Avg volume (3M)
- —
- Shares outstanding
- 53.69M
- Employees
- 158
- Next earnings
- —
About Alpha Teknova, Inc.
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
- ISIN
- US02080L1026
- Founded
- 1996
- Listed since
- Jun 25, 2021
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Evotec SEXTRA: EVT | $550.90M | €2.46 | -11.13% |
| Jiangsu Hanbon Science and Technology Co., Ltd.SHSE: 688755 | $493.26M | CN¥28.88 | -4.50% |
| EirGenix Inc.TWSE: 6589 | $479.15M | NT$51.30 | +0.98% |
| SMO ClinPlus CO.,LTD.SZSE: 301257 | $475.34M | CN¥40.30 | -5.64% |
| Viva Biotech HoldingsSEHK: 1873 | $408.85M | HK$1.55 | +1.31% |
| Zhejiang Tailin BioEngineering Co.,LtdSZSE: 300813 | $403.22M | CN¥22.51 | -1.40% |
| Shin Nippon Biomedical Laboratories, Ltd.TSE: 2395 | $379.40M | ¥1,443.00 | +11.60% |
| Medtide Inc.SEHK: 3880 | $375.12M | HK$20.76 | -1.98% |
Figures last refreshed Oct 11, 2026.